{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "46708-096",
      "generic_name": "lamotrigine chewable dispersible",
      "labeler_name": "Alembic Pharmaceuticals Limited",
      "brand_name": "lamotrigine",
      "active_ingredients": [
        {
          "name": "LAMOTRIGINE",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "46708-096-30",
          "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-096-30)",
          "marketing_start_date": "20160129",
          "sample": false
        },
        {
          "package_ndc": "46708-096-31",
          "description": "100 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-096-31)",
          "marketing_start_date": "20160129",
          "sample": false
        },
        {
          "package_ndc": "46708-096-91",
          "description": "1000 TABLET, FOR SUSPENSION in 1 BOTTLE (46708-096-91)",
          "marketing_start_date": "20160129",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Alembic Pharmaceuticals Limited"
        ],
        "rxcui": [
          "311264",
          "311265"
        ],
        "spl_set_id": [
          "ae6522d4-d824-44aa-afe0-70cdcbd845af"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0346708096304",
          "0346708095307"
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "N0000175751",
          "N0000187061",
          "N0000000191"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]",
          "Mood Stabilizer [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Organic Cation Transporter 2 Inhibitors [MoA]",
          "Dihydrofolate Reductase Inhibitors [MoA]"
        ],
        "unii": [
          "U3H27498KS"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FOR SUSPENSION",
      "spl_id": "4ea08829-6e98-4a5f-97d0-da2d1ac96dc1",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160129",
      "product_id": "46708-096_4ea08829-6e98-4a5f-97d0-da2d1ac96dc1",
      "application_number": "ANDA201168",
      "brand_name_base": "lamotrigine",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Dihydrofolate Reductase Inhibitors [MoA]",
        "Mood Stabilizer [EPC]",
        "Organic Cation Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}